Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression

There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence th...

Full description

Saved in:
Bibliographic Details
Published inTranslational psychiatry Vol. 13; no. 1; pp. 294 - 12
Main Authors Kaurani, Lalit, Besse, Matthias, Methfessel, Isabel, Methi, Aditi, Zhou, Jiayin, Pradhan, Ranjit, Burkhardt, Susanne, Kranaster, Laura, Sartorius, Alexander, Habel, Ute, Grözinger, Michael, Fischer, Andre, Wiltfang, Jens, Zilles-Wegner, David
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 13.09.2023
Nature Publishing Group
Subjects
38/90
38/91
631/378/2584/2585
692/53/2423
692/699/476/1414
Behavioral Sciences
Biological Psychology
Electroconvulsive therapy
Medicine
Medicine & Public Health
Mental depression
MicroRNAs
Neurosciences
Pharmacotherapy
Psychiatry
Online AccessGet full text

Cover

Abstract There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence the transcriptome as well as proteostasis at the systems level. Here, we investigate the role of circulating microRNAs in depression and response prediction towards ECT. Of the 64 patients with treatment-resistant major depression (MDD) who received ECT treatment, 62.5% showed a response, defined as a reduction of ≥50% in the MADRS total score from baseline. We performed smallRNA sequencing in blood samples that were taken before the first ECT, after the first and the last ECT. The microRNAome was compared between responders and non-responders. Co-expression network analysis identified three significant microRNA modules with reverse correlation between ECT- responders and non-responders, that were amongst other biological processes linked to inflammation. A candidate microRNA, namely miR-223-3p was down-regulated in ECT responders when compared to non-responders at baseline. In line with data suggesting a role of miR-223-3p in inflammatory processes we observed higher expression levels of proinflammatory factors Il-6 , Il-1b , Nlrp3 and Tnf-α in ECT responders at baseline when compared to non-responders. ROC analysis of confirmed the diagnostic power of miR-223-3p demarcating ECT-responders from non-responder subjects (AUC = 0.76, p  = 0.0031). Our data suggest that miR-223-3p expression and related cytokine levels could serve as predictors of response to ECT in individuals with treatment-resistant depressive disorders.
AbstractList There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence the transcriptome as well as proteostasis at the systems level. Here, we investigate the role of circulating microRNAs in depression and response prediction towards ECT. Of the 64 patients with treatment-resistant major depression (MDD) who received ECT treatment, 62.5% showed a response, defined as a reduction of ≥50% in the MADRS total score from baseline. We performed smallRNA sequencing in blood samples that were taken before the first ECT, after the first and the last ECT. The microRNAome was compared between responders and non-responders. Co-expression network analysis identified three significant microRNA modules with reverse correlation between ECT- responders and non-responders, that were amongst other biological processes linked to inflammation. A candidate microRNA, namely miR-223-3p was down-regulated in ECT responders when compared to non-responders at baseline. In line with data suggesting a role of miR-223-3p in inflammatory processes we observed higher expression levels of proinflammatory factors Il-6, Il-1b, Nlrp3 and Tnf-α in ECT responders at baseline when compared to non-responders. ROC analysis of confirmed the diagnostic power of miR-223-3p demarcating ECT-responders from non-responder subjects (AUC = 0.76, p = 0.0031). Our data suggest that miR-223-3p expression and related cytokine levels could serve as predictors of response to ECT in individuals with treatment-resistant depressive disorders.
There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence the transcriptome as well as proteostasis at the systems level. Here, we investigate the role of circulating microRNAs in depression and response prediction towards ECT. Of the 64 patients with treatment-resistant major depression (MDD) who received ECT treatment, 62.5% showed a response, defined as a reduction of ≥50% in the MADRS total score from baseline. We performed smallRNA sequencing in blood samples that were taken before the first ECT, after the first and the last ECT. The microRNAome was compared between responders and non-responders. Co-expression network analysis identified three significant microRNA modules with reverse correlation between ECT- responders and non-responders, that were amongst other biological processes linked to inflammation. A candidate microRNA, namely miR-223-3p was down-regulated in ECT responders when compared to non-responders at baseline. In line with data suggesting a role of miR-223-3p in inflammatory processes we observed higher expression levels of proinflammatory factors Il-6 , Il-1b , Nlrp3 and Tnf-α in ECT responders at baseline when compared to non-responders. ROC analysis of confirmed the diagnostic power of miR-223-3p demarcating ECT-responders from non-responder subjects (AUC = 0.76, p  = 0.0031). Our data suggest that miR-223-3p expression and related cytokine levels could serve as predictors of response to ECT in individuals with treatment-resistant depressive disorders.
Abstract There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence the transcriptome as well as proteostasis at the systems level. Here, we investigate the role of circulating microRNAs in depression and response prediction towards ECT. Of the 64 patients with treatment-resistant major depression (MDD) who received ECT treatment, 62.5% showed a response, defined as a reduction of ≥50% in the MADRS total score from baseline. We performed smallRNA sequencing in blood samples that were taken before the first ECT, after the first and the last ECT. The microRNAome was compared between responders and non-responders. Co-expression network analysis identified three significant microRNA modules with reverse correlation between ECT- responders and non-responders, that were amongst other biological processes linked to inflammation. A candidate microRNA, namely miR-223-3p was down-regulated in ECT responders when compared to non-responders at baseline. In line with data suggesting a role of miR-223-3p in inflammatory processes we observed higher expression levels of proinflammatory factors Il-6, Il-1b, Nlrp3 and Tnf-α in ECT responders at baseline when compared to non-responders. ROC analysis of confirmed the diagnostic power of miR-223-3p demarcating ECT-responders from non-responder subjects (AUC = 0.76, p = 0.0031). Our data suggest that miR-223-3p expression and related cytokine levels could serve as predictors of response to ECT in individuals with treatment-resistant depressive disorders.
There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence the transcriptome as well as proteostasis at the systems level. Here, we investigate the role of circulating microRNAs in depression and response prediction towards ECT. Of the 64 patients with treatment-resistant major depression (MDD) who received ECT treatment, 62.5% showed a response, defined as a reduction of ≥50% in the MADRS total score from baseline. We performed smallRNA sequencing in blood samples that were taken before the first ECT, after the first and the last ECT. The microRNAome was compared between responders and non-responders. Co-expression network analysis identified three significant microRNA modules with reverse correlation between ECT- responders and non-responders, that were amongst other biological processes linked to inflammation. A candidate microRNA, namely miR-223-3p was down-regulated in ECT responders when compared to non-responders at baseline. In line with data suggesting a role of miR-223-3p in inflammatory processes we observed higher expression levels of proinflammatory factors Il-6, Il-1b, Nlrp3 and Tnf-α in ECT responders at baseline when compared to non-responders. ROC analysis of confirmed the diagnostic power of miR-223-3p demarcating ECT-responders from non-responder subjects (AUC = 0.76, p = 0.0031). Our data suggest that miR-223-3p expression and related cytokine levels could serve as predictors of response to ECT in individuals with treatment-resistant depressive disorders.There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence the transcriptome as well as proteostasis at the systems level. Here, we investigate the role of circulating microRNAs in depression and response prediction towards ECT. Of the 64 patients with treatment-resistant major depression (MDD) who received ECT treatment, 62.5% showed a response, defined as a reduction of ≥50% in the MADRS total score from baseline. We performed smallRNA sequencing in blood samples that were taken before the first ECT, after the first and the last ECT. The microRNAome was compared between responders and non-responders. Co-expression network analysis identified three significant microRNA modules with reverse correlation between ECT- responders and non-responders, that were amongst other biological processes linked to inflammation. A candidate microRNA, namely miR-223-3p was down-regulated in ECT responders when compared to non-responders at baseline. In line with data suggesting a role of miR-223-3p in inflammatory processes we observed higher expression levels of proinflammatory factors Il-6, Il-1b, Nlrp3 and Tnf-α in ECT responders at baseline when compared to non-responders. ROC analysis of confirmed the diagnostic power of miR-223-3p demarcating ECT-responders from non-responder subjects (AUC = 0.76, p = 0.0031). Our data suggest that miR-223-3p expression and related cytokine levels could serve as predictors of response to ECT in individuals with treatment-resistant depressive disorders.
ArticleNumber 294
Author Besse, Matthias
Methi, Aditi
Fischer, Andre
Habel, Ute
Kranaster, Laura
Zilles-Wegner, David
Pradhan, Ranjit
Kaurani, Lalit
Sartorius, Alexander
Grözinger, Michael
Zhou, Jiayin
Methfessel, Isabel
Burkhardt, Susanne
Wiltfang, Jens
Author_xml – sequence: 1
  givenname: Lalit
  orcidid: 0000-0002-2304-6111
  surname: Kaurani
  fullname: Kaurani, Lalit
  organization: Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases Goettingen
– sequence: 2
  givenname: Matthias
  surname: Besse
  fullname: Besse, Matthias
  organization: Department of Psychiatry and Psychotherapy, University Medical Center Goettingen
– sequence: 3
  givenname: Isabel
  surname: Methfessel
  fullname: Methfessel, Isabel
  organization: Department of Psychiatry and Psychotherapy, University Medical Center Goettingen
– sequence: 4
  givenname: Aditi
  surname: Methi
  fullname: Methi, Aditi
  organization: Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases Goettingen
– sequence: 5
  givenname: Jiayin
  surname: Zhou
  fullname: Zhou, Jiayin
  organization: Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases Goettingen
– sequence: 6
  givenname: Ranjit
  surname: Pradhan
  fullname: Pradhan, Ranjit
  organization: Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases Goettingen
– sequence: 7
  givenname: Susanne
  surname: Burkhardt
  fullname: Burkhardt, Susanne
  organization: Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases Goettingen
– sequence: 8
  givenname: Laura
  orcidid: 0000-0002-8414-0910
  surname: Kranaster
  fullname: Kranaster, Laura
  organization: Department of Psychiatry, Vitos Klinikum Heppenheim
– sequence: 9
  givenname: Alexander
  orcidid: 0000-0002-1243-3693
  surname: Sartorius
  fullname: Sartorius, Alexander
  organization: Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim and University of Heidelberg
– sequence: 10
  givenname: Ute
  orcidid: 0000-0003-0703-7722
  surname: Habel
  fullname: Habel, Ute
  organization: Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University
– sequence: 11
  givenname: Michael
  orcidid: 0000-0001-8700-9646
  surname: Grözinger
  fullname: Grözinger, Michael
  organization: Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University
– sequence: 12
  givenname: Andre
  orcidid: 0000-0001-8546-1161
  surname: Fischer
  fullname: Fischer, Andre
  email: andre.fischer@dzne.de
  organization: Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases Goettingen, Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Cluster of Excellence MBExC, University of Göttingen & University Medical Center Goettingen
– sequence: 13
  givenname: Jens
  orcidid: 0000-0003-1492-5330
  surname: Wiltfang
  fullname: Wiltfang, Jens
  email: Jens.Wiltfang@med.uni-goettingen.de
  organization: Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Clincal Science Group, German Center for Neurodegenerative Diseases (DZNE), Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro
– sequence: 14
  givenname: David
  orcidid: 0000-0002-7531-9732
  surname: Zilles-Wegner
  fullname: Zilles-Wegner, David
  email: david.zilles@med.uni-goettingen.de
  organization: Department of Psychiatry and Psychotherapy, University Medical Center Goettingen
BookMark eNp9Uk1v1DAQjVARLaV_gJMlLlwC_kycE4KKlkqVkBCcLccZ73rl2MFOFvXAf8e7KYL2UEuWx573nmdG72V1EmKAqnpN8DuCmXyfOWGdrDFlZQtJa_6sOqNEyJoRKU_-i0-ri5x3uCzBJWnJi-qUtU3XdRifVb8_6QzeBUAe9uAzihaN7ltNiy6bkIkpgdczoF9u3qJ5CwisBTO7PQTIRzj4ck_RxLBffC6JAyzp6Q65gCY9OwhzXvmj3sWEBphS4boYXlXPrfYZLu7P8-rH1efvl1_q26_XN5cfb2sjiJxrK4QllA5CNFQMAkQjKGhoCGmN4QMnxra2wxxzKg1QYgm3tNFtr3uiLQF2Xt2sukPUOzUlN-p0p6J26vgQ00bpNDvjQQ2cGTb0vNG64yWSjeRFpx_oYDEXbdH6sGpNSz_CYEp3SfsHog8zwW3VJu4VwbxrhcBF4e29Qoo_F8izGl024L0OEJesqGx4Q7qWNAX65hF0F5cUyqyOKEyYlKKg5IoyKeacwCrj5jL4eCjA-fKzOnhGrZ5RxTPq6BnFC5U-ov5t5EkSW0m5gMMG0r-qnmD9AXmf1qA
CitedBy_id crossref_primary_10_1007_s40473_024_00286_7
crossref_primary_10_1007_s11033_024_09554_x
crossref_primary_10_1126_science_adh3707
crossref_primary_10_1016_j_nbd_2024_106785
crossref_primary_10_1007_s11033_025_10230_x
crossref_primary_10_1097_ALN_0000000000005310
crossref_primary_10_3390_ijms25052866
crossref_primary_10_1002_jdn_10410
crossref_primary_10_3389_fphar_2024_1469286
Cites_doi 10.1093/bioinformatics/btv301
10.1007/s13311-021-01140-4
10.15252/emmm.202013659
10.1192/bjp.2017.28
10.1001/2013.jamapsychiatry.4
10.3389/fimmu.2021.781815
10.1038/nrdp.2016.65
10.1371/journal.pone.0069869
10.1038/tp.2016.102
10.1016/j.bionps.2022.100049
10.1002/brb3.1654
10.1038/cr.2017.62
10.3389/fncel.2019.00363
10.4049/jimmunol.1201516
10.3389/fnins.2017.00278
10.1111/acps.12665
10.4088/JCP.20m13287
10.1016/j.carpath.2015.04.007
10.1126/scitranslmed.aah5360
10.1159/000511121
10.1590/1516-4446-2019-0741
10.1159/000506133
10.1016/j.bbi.2013.10.017
10.1038/s41580-018-0059-1
10.1016/j.biopsych.2017.05.013
10.4088/JCP.v66n0101
10.1016/j.bbi.2020.05.069
10.3390/ijerph17082676
10.1007/s40291-020-00464-9
10.1016/j.bbi.2012.12.008
10.1016/j.neuropharm.2022.108984
10.1038/gt.2011.50
10.1111/acps.12576
10.1016/j.biopsych.2021.05.023
10.1038/nbt.2931
10.1038/s41386-021-01002-9
10.3389/fimmu.2019.01696
10.1016/j.brs.2017.10.013
10.1016/j.biopsych.2008.04.016
10.1016/j.jad.2010.05.019
10.1007/s00406-020-01128-9
10.3389/fnins.2019.00098
10.1016/S0006-3223(00)00228-6
10.1016/j.bcp.2014.08.008
10.1016/j.bbi.2017.03.002
10.1186/s12888-015-0577-8
10.1038/s41398-021-01627-w
10.1038/tp.2016.267
10.1186/s12974-021-02100-7
10.1186/1471-2105-9-559
10.1111/ejn.14910
10.1002/gcc.22520
10.1016/j.neuron.2020.06.002
10.1097/00124509-200312000-00002
10.2217/npy.14.3
10.1016/j.jad.2021.02.063
10.1002/1878-0261.12144
10.1101/gr.1239303
10.1016/j.jneuroim.2015.06.004
10.7554/eLife.49115
10.1038/s41467-019-11876-5
10.7150/ijbs.59876
10.1016/j.biopsych.2021.11.016
10.1016/B978-0-323-90053-9.00003-8
10.1002/dvg.22871
10.1016/j.psychres.2021.113735
10.1111/acps.12821
10.1038/tp.2016.131
10.2147/PPA.S29716
10.1517/14656561003614781
10.1007/978-3-030-05542-4_9
10.1038/mp.2011.162
10.1016/j.jad.2018.07.075
10.1038/s41577-019-0165-0
10.3390/cells9071618
ContentType Journal Article
Copyright The Author(s) 2023
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023. Springer Nature Limited.
Springer Nature Limited 2023
Copyright_xml – notice: The Author(s) 2023
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023. Springer Nature Limited.
– notice: Springer Nature Limited 2023
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1038/s41398-023-02582-4
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
CrossRef


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2158-3188
EndPage 12
ExternalDocumentID oai_doaj_org_article_d43c3db46aa94c3d8684babbd2df0457
PMC10497550
10_1038_s41398_023_02582_4
GroupedDBID ---
0R~
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAJSJ
AAKDD
ABUWG
ACGFO
ACGFS
ACMJI
ACSMW
ADBBV
ADFRT
AENEX
AFKRA
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EMOBN
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
KQ8
LGEZI
LOTEE
M1P
M~E
NADUK
NAO
NXXTH
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
7XB
8FK
AARCD
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c518t-f55f122d55625d5e5652eae6117cc4d41cf7f9040428ce21f14f26a7bab1af1e3
IEDL.DBID C6C
ISSN 2158-3188
IngestDate Wed Aug 27 01:17:13 EDT 2025
Thu Aug 21 18:36:28 EDT 2025
Fri Jul 11 01:54:22 EDT 2025
Wed Aug 13 09:29:00 EDT 2025
Thu Apr 24 22:56:57 EDT 2025
Tue Jul 01 00:55:25 EDT 2025
Fri Feb 21 02:39:09 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c518t-f55f122d55625d5e5652eae6117cc4d41cf7f9040428ce21f14f26a7bab1af1e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8414-0910
0000-0003-1492-5330
0000-0002-7531-9732
0000-0001-8700-9646
0000-0001-8546-1161
0000-0002-1243-3693
0000-0002-2304-6111
0000-0003-0703-7722
OpenAccessLink https://www.nature.com/articles/s41398-023-02582-4
PMID 37699900
PQID 2864013885
PQPubID 2041978
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_d43c3db46aa94c3d8684babbd2df0457
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10497550
proquest_miscellaneous_2864619716
proquest_journals_2864013885
crossref_citationtrail_10_1038_s41398_023_02582_4
crossref_primary_10_1038_s41398_023_02582_4
springer_journals_10_1038_s41398_023_02582_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-09-13
PublicationDateYYYYMMDD 2023-09-13
PublicationDate_xml – month: 09
  year: 2023
  text: 2023-09-13
  day: 13
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Translational psychiatry
PublicationTitleAbbrev Transl Psychiatry
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Goldberg, Islam, Kerimoglu, Lancelin, Gisa, Burkhardt (CR22) 2021; 11
Bayraktar, Van Roosbroeck, Calin (CR19) 2017; 11
Kaufmann, Costa, Ghisleni, Diaz, Rodrigues, Peluffo (CR39) 2017; 64
Iwata, Ota, Duman (CR62) 2013; 31
Inta, Lima-Ojeda, Lau, Tang, Dormann, Sprengel (CR37) 2013; 8
Risso, Ngai, Speed, Dudoit (CR30) 2014; 32
Jiao, Wang, Luoreng, Yang, Jia, Ma (CR54) 2021; 17
Men, Yelick, Jin, Tian, Chiang, Higashimori (CR75) 2019; 10
Ye, Xiao, Xu, Zheng, Chen, Luo (CR80) 2022; 208
Broderick, Zamore (CR14) 2011; 18
Schoenfeld, McCausland, Morris, Padmanaban, Cameron (CR46) 2017; 82
Gorinski, Bijata, Prasad, Wirth, Abdel Galil, Zeug (CR51) 2019; 10
Brymer, Romay-Tallon, Allen, Caruncho, Kalynchuk (CR78) 2019; 13
Badhwar, Haqqani (CR77) 2020; 12
Moreira, Cardoso, de, Mondin, Souza, de (CR70) 2015; 285
Shannon, Markiel, Ozier, Baliga, Wang, Ramage (CR33) 2003; 13
Lin, Hung, Chen, Tsou, Fong, Wang (CR6) 2014; 91
Jose (CR20) 2015; 53
Cuomo-Haymour, Kaiser, Hartmann-Riemer, Guetter, Klaus, Cathomas (CR35) 2022; 6
Nøhr, Lindow, Forsingdal, Demharter, Nielsen, Buller (CR9) 2021; 46
Love, Huber, Anders (CR31) 2014; 15
CR5
Dwivedi (CR17) 2018; 240
Xu, Liu, Li, Sun, Ren, Liu (CR50) 2010; 127
Kruse, Olmstead, Hellemann, Wade, Jiang, Vasavada (CR27) 2020; 89
Das, Halushka (CR73) 2015; 24
van Diermen, Poljac, Van der Mast, Plasmans, Van den Ameele, Heijnen (CR43) 2020; 82
Neudecker, Brodsky, Clambey, Schmidt, Packard, Davenport (CR57) 2017; 9
Borza, Engedal, Bergh, Benth, Selbæk (CR26) 2015; 15
Swanson, Deng, Ting (CR60) 2019; 19
Gururajan, Naughton, Scott, O’Connor, Moloney, Clarke (CR24) 2016; 6
Blanco, Conant (CR45) 2021; 53
Järventausta, Sorri, Kampman, Björkqvist, Tuohimaa, Hämäläinen (CR38) 2017; 135
Borrione, Bellini, Razza, Avila, Baeken, Brem (CR41) 2020; 42
Cano, Martínez-Zalacaín, Bernabéu-Sanz, Contreras-Rodríguez, Hernández-Ribas, Via (CR11) 2017; 7
Al-Harbi (CR52) 2012; 6
Leaver, Espinoza, Wade, Narr (CR13) 2022; 92
Madsen, Treschow, Bengzon, Bolwig, Lindvall, Tingström (CR47) 2000; 47
Mustapic, Eitan, Werner, Berkowitz, Lazaropoulos, Tran (CR21) 2017; 11
Marsland, Gianaros, Abramowitch, Manuck, Hariri (CR64) 2008; 64
Ma, Rosenheck, Ye, Fan, He (CR10) 2020; 10
Pirnia, Joshi, Leaver, Vasavada, Njau, Woods (CR36) 2016; 6
Faust, Vajkoczy, Xi, Harnack (CR8) 2021; 99
Gutiérrez-Sacristán, Grosdidier, Valverde, Torrens, Bravo, Piñero (CR34) 2015; 31
Philip, Carpenter, Tyrka, Price (CR2) 2010; 11
Xu, Zhang, Du, Li, Zi, Bu (CR74) 2017; 27
Kerner, Prudic (CR12) 2014; 4
CR55
Fries, Zhang, Benevenuto, Quevedo (CR3) 2019; 1118
Roy, Yoshino, Allen, Prall, Schell, Dwivedi (CR25) 2020; 24
van Diermen, van den Ameele, Kamperman, Sabbe, Vermeulen, Schrijvers (CR42) 2018; 212
Qu, Liu, Chen, Zheng, Chen (CR59) 2020; 17
Lee, Giuliani (CR67) 2019; 10
Zhou, Zhu, Chen, Tang (CR18) 2021; 286
Nogueras-Ortiz, Mahairaki, Delgado-Peraza, Das, Avgerinos, Eren (CR76) 2020; 9
Gay, Romeo, Martelli, Benyamina, Hamdani (CR68) 2021; 297
Beurel, Toups, Nemeroff (CR66) 2020; 107
Islam, Kaurani, Berulava, Heilbronner, Budde, Centeno (CR32) 2021; 13
Tian, Li, Xu, Liu, Wan, Zhang (CR63) 2021; 271
Belge, van Diermen, Sabbe, Parizel, Morrens, Coppens (CR44) 2020; 79
Hestad, Tønseth, Støen, Ueland, Aukrust (CR72) 2003; 19
Otte, Gold, Penninx, Pariante, Etkin, Fava (CR4) 2016; 2
Argyelan, Oltedal, Deng, Wade, Bikson, Joanlanne (CR49) 2019; 8
Kolshus, Ryan, Blackshields, Smyth, Sheils, McLoughlin (CR1) 2017; 136
Treiber, Treiber, Meister (CR16) 2019; 20
Raison, Rutherford, Woolwine, Shuo, Schettler, Drake (CR79) 2013; 70
Yuan, Wu, Wang, Che, Zheng, Chen (CR58) 2021; 12
Mullany, Herrick, Wolff, Stevens, Samowitz, Slattery (CR15) 2018; 57
Langfelder, Horvath (CR29) 2008; 9
Langmead, Trapnell, Pop, Salzberg (CR28) 2009; 10
Bauernfeind, Rieger, Schildberg, Knolle, Schmid-Burgk, Hornung (CR56) 2012; 189
Yrondi, Sporer, Péran, Schmitt, Arbus, Sauvaget (CR71) 2018; 11
Alcocer-Gómez, de Miguel, Casas-Barquero, Núñez-Vasco, Sánchez-Alcazar, Fernández-Rodríguez (CR61) 2014; 36
Roohi, Jaafari, Hashemian (CR65) 2021; 18
Miranda, Morici, Zanoni, Bekinschtein (CR7) 2019; 13
Ousdal, Brancati, Kessler, Erchinger, Dale, Abbott (CR48) 2022; 91
Dahl, Ormstad, Aass, Sandvik, Malt, Andreassen (CR69) 2016; 134
Muhammad, Ahmed, Abdul Salam, Ahmed, Attia (CR40) 2021; 18
O’Connor, Dinan, Cryan (CR23) 2012; 17
Keller (CR53) 2005; 66
J-B Belge (2582_CR44) 2020; 79
LE Mullany (2582_CR15) 2018; 57
L van Diermen (2582_CR43) 2020; 82
E Roohi (2582_CR65) 2021; 18
M Cano (2582_CR11) 2017; 7
I Blanco (2582_CR45) 2021; 53
JL Kruse (2582_CR27) 2020; 89
K Faust (2582_CR8) 2021; 99
RM O’Connor (2582_CR23) 2012; 17
CJ Nogueras-Ortiz (2582_CR76) 2020; 9
F Gay (2582_CR68) 2021; 297
GR Fries (2582_CR3) 2019; 1118
C-H Lee (2582_CR67) 2019; 10
J Dahl (2582_CR69) 2016; 134
L Zhou (2582_CR18) 2021; 286
KS Al-Harbi (2582_CR52) 2012; 6
N Kerner (2582_CR12) 2014; 4
MR Islam (2582_CR32) 2021; 13
N Gorinski (2582_CR51) 2019; 10
S Yuan (2582_CR58) 2021; 12
RN Muhammad (2582_CR40) 2021; 18
C-Y Lin (2582_CR6) 2014; 91
P Jiao (2582_CR54) 2021; 17
A Yrondi (2582_CR71) 2018; 11
D Risso (2582_CR30) 2014; 32
H Tian (2582_CR63) 2021; 271
Y Dwivedi (2582_CR17) 2018; 240
T Borza (2582_CR26) 2015; 15
M Argyelan (2582_CR49) 2019; 8
AK Nøhr (2582_CR9) 2021; 46
Y Men (2582_CR75) 2019; 10
M Mustapic (2582_CR21) 2017; 11
TM Madsen (2582_CR47) 2000; 47
2582_CR5
TJ Schoenfeld (2582_CR46) 2017; 82
C Otte (2582_CR4) 2016; 2
N Cuomo-Haymour (2582_CR35) 2022; 6
Y Xu (2582_CR50) 2010; 127
KJ Brymer (2582_CR78) 2019; 13
AM Jose (2582_CR20) 2015; 53
AM Leaver (2582_CR13) 2022; 92
T Treiber (2582_CR16) 2019; 20
MB Keller (2582_CR53) 2005; 66
L Ye (2582_CR80) 2022; 208
A Gutiérrez-Sacristán (2582_CR34) 2015; 31
KV Swanson (2582_CR60) 2019; 19
AL Marsland (2582_CR64) 2008; 64
P Shannon (2582_CR33) 2003; 13
2582_CR55
OT Ousdal (2582_CR48) 2022; 91
JA Broderick (2582_CR14) 2011; 18
T Pirnia (2582_CR36) 2016; 6
M Miranda (2582_CR7) 2019; 13
FN Kaufmann (2582_CR39) 2017; 64
K Järventausta (2582_CR38) 2017; 135
E Beurel (2582_CR66) 2020; 107
P Langfelder (2582_CR29) 2008; 9
V Neudecker (2582_CR57) 2017; 9
H Qu (2582_CR59) 2020; 17
L Borrione (2582_CR41) 2020; 42
MI Love (2582_CR31) 2014; 15
D Inta (2582_CR37) 2013; 8
E Kolshus (2582_CR1) 2017; 136
S Das (2582_CR73) 2015; 24
KA Hestad (2582_CR72) 2003; 19
B Xu (2582_CR74) 2017; 27
A Badhwar (2582_CR77) 2020; 12
L van Diermen (2582_CR42) 2018; 212
CL Raison (2582_CR79) 2013; 70
FP Moreira (2582_CR70) 2015; 285
Y Ma (2582_CR10) 2020; 10
R Bayraktar (2582_CR19) 2017; 11
E Alcocer-Gómez (2582_CR61) 2014; 36
M Iwata (2582_CR62) 2013; 31
F Bauernfeind (2582_CR56) 2012; 189
B Langmead (2582_CR28) 2009; 10
A Gururajan (2582_CR24) 2016; 6
B Roy (2582_CR25) 2020; 24
NS Philip (2582_CR2) 2010; 11
M Goldberg (2582_CR22) 2021; 11
References_xml – volume: 189
  start-page: 4175
  year: 2012
  end-page: 81
  ident: CR56
  article-title: NLRP3 inflammasome activity is negatively controlled by miR-223
  publication-title: J Immunol
– volume: 286
  start-page: 80
  year: 2021
  end-page: 6
  ident: CR18
  article-title: Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response
  publication-title: J Affect Disord
– volume: 10
  start-page: 1696
  year: 2019
  ident: CR67
  article-title: The role of inflammation in depression and fatigue
  publication-title: Front Immunol
– volume: 208
  start-page: 108984
  year: 2022
  ident: CR80
  article-title: Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions
  publication-title: Neuropharmacology.
– volume: 46
  start-page: 1324
  year: 2021
  end-page: 32
  ident: CR9
  article-title: A large-scale genome-wide gene expression analysis in peripheral blood identifies very few differentially expressed genes related to antidepressant treatment and response in patients with major depressive disorder
  publication-title: Neuropsychopharmacology.
– volume: 9
  year: 2008
  ident: CR29
  article-title: WGCNA: an R package for weighted correlation network analysis
  publication-title: BMC Bioinforma
– volume: 11
  start-page: 1673
  year: 2017
  end-page: 86
  ident: CR19
  article-title: Cell‐to‐cell communication: microRNAs as hormones
  publication-title: Mol Oncol
– volume: 271
  start-page: 475
  year: 2021
  end-page: 85
  ident: CR63
  article-title: Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder
  publication-title: Eur Arch Psychiatry Clin Neurosci
– volume: 107
  start-page: 234
  year: 2020
  end-page: 56
  ident: CR66
  article-title: The bidirectional relationship of depression and inflammation: double trouble
  publication-title: Neuron.
– volume: 6
  start-page: 369
  year: 2012
  end-page: 88
  ident: CR52
  article-title: Treatment-resistant depression: therapeutic trends, challenges, and future directions
  publication-title: Patient Prefer Adherence
– volume: 53
  start-page: 3879
  year: 2021
  end-page: 88
  ident: CR45
  article-title: Extracellular matrix remodeling with stress and depression: studies in human, rodent and zebrafish models
  publication-title: Eur J Neurosci
– volume: 91
  start-page: 540
  year: 2022
  end-page: 9
  ident: CR48
  article-title: The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: what have we learned, and where do we go?
  publication-title: Biol Psychiatry
– volume: 79
  start-page: 222
  year: 2020
  end-page: 32
  ident: CR44
  article-title: Inflammation, hippocampal volume, and therapeutic outcome following electroconvulsive therapy in depressive patients: a pilot study
  publication-title: Neuropsychobiology.
– volume: 91
  start-page: 522
  year: 2014
  end-page: 33
  ident: CR6
  article-title: Brain-derived neurotrophic factor increases vascular endothelial growth factor expression and enhances angiogenesis in human chondrosarcoma cells
  publication-title: Biochem Pharmacol
– volume: 9
  start-page: 1618
  year: 2020
  ident: CR76
  article-title: Astrocyte- and neuron-derived extracellular vesicles from Alzheimer’s disease patients effect complement-mediated neurotoxicity
  publication-title: Cells.
– volume: 13
  start-page: 98
  year: 2019
  ident: CR78
  article-title: Exploring the potential antidepressant mechanisms of TNFα antagonists
  publication-title: Front Neurosci
– volume: 6
  start-page: 100049
  year: 2022
  ident: CR35
  article-title: Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorder
  publication-title: Biomark Neuropsychiatry
– volume: 82
  start-page: 20m13287
  year: 2020
  ident: CR43
  article-title: Toward targeted ECT: the interdependence of predictors of treatment response in depression further explained
  publication-title: J Clin Psychiatry
– volume: 19
  start-page: 183
  year: 2003
  end-page: 8
  ident: CR72
  article-title: Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy
  publication-title: J ECT
– volume: 11
  start-page: 29
  year: 2018
  end-page: 51
  ident: CR71
  article-title: Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review
  publication-title: Brain Stimul
– volume: 42
  start-page: 403
  year: 2020
  end-page: 19
  ident: CR41
  article-title: Precision non-implantable neuromodulation therapies: a perspective for the depressed brain
  publication-title: Braz J Psychiatry
– volume: 12
  start-page: e12001
  year: 2020
  ident: CR77
  article-title: Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer’s disease
  publication-title: Alzheimers Dement
– volume: 240
  start-page: 146
  year: 2018
  end-page: 54
  ident: CR17
  article-title: MicroRNAs in depression and suicide: recent insights and future perspectives
  publication-title: J Affect Disord
– volume: 32
  start-page: 896
  year: 2014
  end-page: 902
  ident: CR30
  article-title: Normalization of RNA-seq data using factor analysis of control genes or samples
  publication-title: Nat Biotechnol
– volume: 10
  year: 2009
  ident: CR28
  article-title: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
  publication-title: Genome Biol
– volume: 127
  start-page: 332
  year: 2010
  end-page: 6
  ident: CR50
  article-title: A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform
  publication-title: J Affect Disord
– volume: 82
  start-page: 914
  year: 2017
  end-page: 23
  ident: CR46
  article-title: Stress and loss of adult neurogenesis differentially reduce hippocampal volume
  publication-title: Biol Psychiatry
– ident: CR5
– volume: 13
  start-page: e13659
  year: 2021
  ident: CR32
  article-title: A microRNA signature that correlates with cognition and is a target against cognitive decline
  publication-title: EMBO Mol Med
– volume: 6
  year: 2016
  ident: CR36
  article-title: Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex
  publication-title: Transl Psychiatry
– volume: 13
  start-page: 363.
  year: 2019
  ident: CR7
  article-title: Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain
  publication-title: Front Cell Neurosci
– volume: 4
  start-page: 33
  year: 2014
  end-page: 54
  ident: CR12
  article-title: Current electroconvulsive therapy practice and research in the geriatric population
  publication-title: Neuropsychiatry
– volume: 10
  start-page: e01654
  year: 2020
  ident: CR10
  article-title: Effectiveness of electroconvulsive therapy in patients with “less treatment‐resistant” depression by the Maudsley Staging Model
  publication-title: Brain Behav
– volume: 92
  start-page: 193
  year: 2022
  end-page: 203
  ident: CR13
  article-title: Parsing the network mechanisms of electroconvulsive therapy
  publication-title: Biol Psychiatry
– volume: 24
  start-page: 279
  year: 2020
  end-page: 98
  ident: CR25
  article-title: Exploiting circulating micrornas as biomarkers in psychiatric disorders
  publication-title: Mol Diagn Ther
– volume: 134
  start-page: 40
  year: 2016
  end-page: 47
  ident: CR69
  article-title: Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels
  publication-title: Acta Psychiatr Scand
– volume: 297
  start-page: 113735
  year: 2021
  ident: CR68
  article-title: Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a meta-analysis
  publication-title: Psychiatry Res
– volume: 70
  start-page: 31
  year: 2013
  end-page: 41
  ident: CR79
  article-title: A randomized controlled trial of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant depression: role of baseline inflammatory biomarkers
  publication-title: JAMA Psychiatry
– volume: 66
  start-page: 5
  year: 2005
  end-page: 12
  ident: CR53
  article-title: Issues in treatment-resistant depression
  publication-title: J Clin Psychiatry
– volume: 17
  start-page: 2676
  year: 2020
  ident: CR59
  article-title: Aerobic exercise inhibits CUMS-depressed mice hippocampal inflammatory response via activating hippocampal miR-223/TLR4/MyD88-NF-κB pathway
  publication-title: Int J Environ Res Public Health
– volume: 47
  start-page: 1043
  year: 2000
  end-page: 9
  ident: CR47
  article-title: Increased neurogenesis in a model of electroconvulsive therapy
  publication-title: Biol Psychiatry
– volume: 53
  start-page: 395
  year: 2015
  end-page: 416
  ident: CR20
  article-title: Movement of regulatory RNA between animal cells
  publication-title: Genesis.
– volume: 64
  start-page: 367
  year: 2017
  end-page: 83
  ident: CR39
  article-title: NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings
  publication-title: Brain Behav Immun
– volume: 10
  year: 2019
  ident: CR51
  article-title: Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors
  publication-title: Nat Commun
– volume: 24
  start-page: 199
  year: 2015
  end-page: 206
  ident: CR73
  article-title: Extracellular vesicle microRNA transfer in cardiovascular disease
  publication-title: Cardiovasc Pathol
– volume: 7
  year: 2017
  ident: CR11
  article-title: Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study
  publication-title: Transl Psychiatry
– volume: 11
  start-page: 1
  year: 2021
  end-page: 13
  ident: CR22
  article-title: Exercise as a model to identify microRNAs linked to human cognition: a role for microRNA-409 and microRNA-501
  publication-title: Transl Psychiatry
– volume: 8
  start-page: e49115
  year: 2019
  ident: CR49
  article-title: Electric field causes volumetric changes in the human brain
  publication-title: eLife
– volume: 20
  start-page: 5
  year: 2019
  end-page: 20
  ident: CR16
  article-title: Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
  publication-title: Nat Rev Mol Cell Biol
– volume: 27
  start-page: 882
  year: 2017
  end-page: 97
  ident: CR74
  article-title: Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity
  publication-title: Cell Res
– volume: 99
  start-page: 256
  year: 2021
  end-page: 66
  ident: CR8
  article-title: The effects of deep brain stimulation of the subthalamic nucleus on vascular endothelial growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in a rat model of Parkinson’s disease
  publication-title: Stereotact Funct Neurosurg
– volume: 18
  start-page: 2664
  year: 2021
  end-page: 81
  ident: CR40
  article-title: Crosstalk among NLRP3 inflammasome, ETBR signaling, and miRNAs in stress-induced depression-like behavior: a modulatory role for SGLT2 inhibitors
  publication-title: Neurotherapeutics.
– volume: 17
  start-page: 2308
  year: 2021
  end-page: 22
  ident: CR54
  article-title: miR-223: an effective regulator of immune cell differentiation and inflammation
  publication-title: Int J Biol Sci
– volume: 285
  start-page: 143
  year: 2015
  end-page: 6
  ident: CR70
  article-title: The effect of proinflammatory cytokines in cognitive behavioral therapy
  publication-title: J Neuroimmunol
– volume: 212
  start-page: 71
  year: 2018
  end-page: 80
  ident: CR42
  article-title: Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis
  publication-title: Br J Psychiatry
– volume: 31
  start-page: 105
  year: 2013
  end-page: 14
  ident: CR62
  article-title: The inflammasome: pathways linking psychological stress, depression, and systemic illnesses
  publication-title: Brain Behav Immun
– volume: 17
  start-page: 359
  year: 2012
  end-page: 76
  ident: CR23
  article-title: Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression
  publication-title: Mol Psychiatry
– volume: 6
  year: 2016
  ident: CR24
  article-title: MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c
  publication-title: Transl Psychiatry
– volume: 15
  year: 2014
  ident: CR31
  article-title: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
  publication-title: Genome Biol
– volume: 2
  start-page: 16065
  year: 2016
  ident: CR4
  article-title: Major depressive disorder
  publication-title: Nat Rev Dis Prim
– volume: 57
  start-page: 192
  year: 2018
  end-page: 202
  ident: CR15
  article-title: MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases
  publication-title: Genes Chromosomes Cancer
– volume: 11
  start-page: 278
  year: 2017
  ident: CR21
  article-title: Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes
  publication-title: Front Neurosci
– volume: 13
  start-page: 2498
  year: 2003
  end-page: 504
  ident: CR33
  article-title: Cytoscape: a software environment for integrated models of biomolecular interaction networks
  publication-title: Genome Res
– volume: 18
  year: 2021
  ident: CR65
  article-title: On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
  publication-title: J Neuroinflammation
– volume: 8
  start-page: e69869
  year: 2013
  ident: CR37
  article-title: Electroconvulsive therapy induces neurogenesis in frontal rat brain areas
  publication-title: PLoS ONE
– volume: 11
  start-page: 709
  year: 2010
  end-page: 22
  ident: CR2
  article-title: Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era
  publication-title: Expert Opin Pharmacother
– volume: 19
  start-page: 477
  year: 2019
  end-page: 89
  ident: CR60
  article-title: The NLRP3 inflammasome: molecular activation and regulation to therapeutics
  publication-title: Nat Rev Immunol
– volume: 10
  year: 2019
  ident: CR75
  article-title: Exosome reporter mice reveal the involvement of exosomes in mediating neuron to astroglia communication in the CNS
  publication-title: Nat Commun
– volume: 135
  start-page: 87
  year: 2017
  end-page: 92
  ident: CR38
  article-title: Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression
  publication-title: Acta Psychiatr Scand
– ident: CR55
– volume: 31
  start-page: 3075
  year: 2015
  end-page: 7
  ident: CR34
  article-title: PsyGeNET: a knowledge platform on psychiatric disorders and their genes
  publication-title: Bioinformatics.
– volume: 89
  start-page: 59
  year: 2020
  end-page: 66
  ident: CR27
  article-title: Inflammation and depression treatment response to electroconvulsive therapy: sex-specific role of interleukin-8
  publication-title: Brain Behav Immun
– volume: 9
  start-page: eaah5360
  year: 2017
  ident: CR57
  article-title: Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice
  publication-title: Sci Transl Med
– volume: 36
  start-page: 111
  year: 2014
  end-page: 7
  ident: CR61
  article-title: NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder
  publication-title: Brain Behav Immun
– volume: 64
  start-page: 484
  year: 2008
  end-page: 90
  ident: CR64
  article-title: Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults
  publication-title: Biol Psychiatry
– volume: 1118
  start-page: 175
  year: 2019
  end-page: 90
  ident: CR3
  article-title: MicroRNAs in major depressive disorder
  publication-title: Adv Exp Med Biol
– volume: 136
  start-page: 594
  year: 2017
  end-page: 606
  ident: CR1
  article-title: Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression
  publication-title: Acta Psychiatr Scand
– volume: 18
  start-page: 1104
  year: 2011
  end-page: 10
  ident: CR14
  article-title: MicroRNA therapeutics
  publication-title: Gene Ther
– volume: 15
  year: 2015
  ident: CR26
  article-title: The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients
  publication-title: BMC Psychiatry
– volume: 12
  start-page: 781815
  year: 2021
  ident: CR58
  article-title: miR-223: an immune regulator in infectious disorders
  publication-title: Front Immunol
– volume: 31
  start-page: 3075
  year: 2015
  ident: 2582_CR34
  publication-title: Bioinformatics.
  doi: 10.1093/bioinformatics/btv301
– volume: 18
  start-page: 2664
  year: 2021
  ident: 2582_CR40
  publication-title: Neurotherapeutics.
  doi: 10.1007/s13311-021-01140-4
– volume: 13
  start-page: e13659
  year: 2021
  ident: 2582_CR32
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.202013659
– volume: 212
  start-page: 71
  year: 2018
  ident: 2582_CR42
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.2017.28
– volume: 70
  start-page: 31
  year: 2013
  ident: 2582_CR79
  publication-title: JAMA Psychiatry
  doi: 10.1001/2013.jamapsychiatry.4
– volume: 12
  start-page: 781815
  year: 2021
  ident: 2582_CR58
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.781815
– volume: 2
  start-page: 16065
  year: 2016
  ident: 2582_CR4
  publication-title: Nat Rev Dis Prim
  doi: 10.1038/nrdp.2016.65
– volume: 8
  start-page: e69869
  year: 2013
  ident: 2582_CR37
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0069869
– volume: 6
  year: 2016
  ident: 2582_CR36
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2016.102
– volume: 6
  start-page: 100049
  year: 2022
  ident: 2582_CR35
  publication-title: Biomark Neuropsychiatry
  doi: 10.1016/j.bionps.2022.100049
– volume: 10
  start-page: e01654
  year: 2020
  ident: 2582_CR10
  publication-title: Brain Behav
  doi: 10.1002/brb3.1654
– volume: 27
  start-page: 882
  year: 2017
  ident: 2582_CR74
  publication-title: Cell Res
  doi: 10.1038/cr.2017.62
– volume: 12
  start-page: e12001
  year: 2020
  ident: 2582_CR77
  publication-title: Alzheimers Dement
– volume: 13
  start-page: 363.
  year: 2019
  ident: 2582_CR7
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2019.00363
– volume: 189
  start-page: 4175
  year: 2012
  ident: 2582_CR56
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1201516
– volume: 11
  start-page: 278
  year: 2017
  ident: 2582_CR21
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2017.00278
– volume: 135
  start-page: 87
  year: 2017
  ident: 2582_CR38
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12665
– volume: 82
  start-page: 20m13287
  year: 2020
  ident: 2582_CR43
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.20m13287
– volume: 24
  start-page: 199
  year: 2015
  ident: 2582_CR73
  publication-title: Cardiovasc Pathol
  doi: 10.1016/j.carpath.2015.04.007
– volume: 9
  start-page: eaah5360
  year: 2017
  ident: 2582_CR57
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aah5360
– volume: 99
  start-page: 256
  year: 2021
  ident: 2582_CR8
  publication-title: Stereotact Funct Neurosurg
  doi: 10.1159/000511121
– volume: 42
  start-page: 403
  year: 2020
  ident: 2582_CR41
  publication-title: Braz J Psychiatry
  doi: 10.1590/1516-4446-2019-0741
– volume: 79
  start-page: 222
  year: 2020
  ident: 2582_CR44
  publication-title: Neuropsychobiology.
  doi: 10.1159/000506133
– volume: 36
  start-page: 111
  year: 2014
  ident: 2582_CR61
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2013.10.017
– volume: 20
  start-page: 5
  year: 2019
  ident: 2582_CR16
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-018-0059-1
– volume: 82
  start-page: 914
  year: 2017
  ident: 2582_CR46
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2017.05.013
– volume: 66
  start-page: 5
  year: 2005
  ident: 2582_CR53
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.v66n0101
– volume: 89
  start-page: 59
  year: 2020
  ident: 2582_CR27
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2020.05.069
– volume: 17
  start-page: 2676
  year: 2020
  ident: 2582_CR59
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph17082676
– volume: 24
  start-page: 279
  year: 2020
  ident: 2582_CR25
  publication-title: Mol Diagn Ther
  doi: 10.1007/s40291-020-00464-9
– volume: 31
  start-page: 105
  year: 2013
  ident: 2582_CR62
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2012.12.008
– volume: 208
  start-page: 108984
  year: 2022
  ident: 2582_CR80
  publication-title: Neuropharmacology.
  doi: 10.1016/j.neuropharm.2022.108984
– volume: 15
  year: 2014
  ident: 2582_CR31
  publication-title: Genome Biol
– ident: 2582_CR5
– volume: 10
  year: 2019
  ident: 2582_CR75
  publication-title: Nat Commun
– volume: 10
  year: 2009
  ident: 2582_CR28
  publication-title: Genome Biol
– volume: 18
  start-page: 1104
  year: 2011
  ident: 2582_CR14
  publication-title: Gene Ther
  doi: 10.1038/gt.2011.50
– volume: 134
  start-page: 40
  year: 2016
  ident: 2582_CR69
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12576
– volume: 91
  start-page: 540
  year: 2022
  ident: 2582_CR48
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2021.05.023
– volume: 32
  start-page: 896
  year: 2014
  ident: 2582_CR30
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2931
– volume: 46
  start-page: 1324
  year: 2021
  ident: 2582_CR9
  publication-title: Neuropsychopharmacology.
  doi: 10.1038/s41386-021-01002-9
– volume: 10
  start-page: 1696
  year: 2019
  ident: 2582_CR67
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01696
– volume: 11
  start-page: 29
  year: 2018
  ident: 2582_CR71
  publication-title: Brain Stimul
  doi: 10.1016/j.brs.2017.10.013
– volume: 64
  start-page: 484
  year: 2008
  ident: 2582_CR64
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2008.04.016
– volume: 127
  start-page: 332
  year: 2010
  ident: 2582_CR50
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2010.05.019
– volume: 271
  start-page: 475
  year: 2021
  ident: 2582_CR63
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-020-01128-9
– volume: 13
  start-page: 98
  year: 2019
  ident: 2582_CR78
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2019.00098
– volume: 47
  start-page: 1043
  year: 2000
  ident: 2582_CR47
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(00)00228-6
– volume: 91
  start-page: 522
  year: 2014
  ident: 2582_CR6
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2014.08.008
– volume: 64
  start-page: 367
  year: 2017
  ident: 2582_CR39
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2017.03.002
– volume: 15
  year: 2015
  ident: 2582_CR26
  publication-title: BMC Psychiatry
  doi: 10.1186/s12888-015-0577-8
– volume: 11
  start-page: 1
  year: 2021
  ident: 2582_CR22
  publication-title: Transl Psychiatry
  doi: 10.1038/s41398-021-01627-w
– volume: 7
  year: 2017
  ident: 2582_CR11
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2016.267
– volume: 18
  year: 2021
  ident: 2582_CR65
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-021-02100-7
– volume: 9
  year: 2008
  ident: 2582_CR29
  publication-title: BMC Bioinforma
  doi: 10.1186/1471-2105-9-559
– volume: 53
  start-page: 3879
  year: 2021
  ident: 2582_CR45
  publication-title: Eur J Neurosci
  doi: 10.1111/ejn.14910
– volume: 57
  start-page: 192
  year: 2018
  ident: 2582_CR15
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.22520
– volume: 107
  start-page: 234
  year: 2020
  ident: 2582_CR66
  publication-title: Neuron.
  doi: 10.1016/j.neuron.2020.06.002
– volume: 19
  start-page: 183
  year: 2003
  ident: 2582_CR72
  publication-title: J ECT
  doi: 10.1097/00124509-200312000-00002
– volume: 4
  start-page: 33
  year: 2014
  ident: 2582_CR12
  publication-title: Neuropsychiatry
  doi: 10.2217/npy.14.3
– volume: 286
  start-page: 80
  year: 2021
  ident: 2582_CR18
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2021.02.063
– volume: 11
  start-page: 1673
  year: 2017
  ident: 2582_CR19
  publication-title: Mol Oncol
  doi: 10.1002/1878-0261.12144
– volume: 13
  start-page: 2498
  year: 2003
  ident: 2582_CR33
  publication-title: Genome Res
  doi: 10.1101/gr.1239303
– volume: 285
  start-page: 143
  year: 2015
  ident: 2582_CR70
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2015.06.004
– volume: 8
  start-page: e49115
  year: 2019
  ident: 2582_CR49
  publication-title: eLife
  doi: 10.7554/eLife.49115
– volume: 10
  year: 2019
  ident: 2582_CR51
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-11876-5
– volume: 17
  start-page: 2308
  year: 2021
  ident: 2582_CR54
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.59876
– volume: 92
  start-page: 193
  year: 2022
  ident: 2582_CR13
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2021.11.016
– ident: 2582_CR55
  doi: 10.1016/B978-0-323-90053-9.00003-8
– volume: 53
  start-page: 395
  year: 2015
  ident: 2582_CR20
  publication-title: Genesis.
  doi: 10.1002/dvg.22871
– volume: 297
  start-page: 113735
  year: 2021
  ident: 2582_CR68
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2021.113735
– volume: 136
  start-page: 594
  year: 2017
  ident: 2582_CR1
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12821
– volume: 6
  year: 2016
  ident: 2582_CR24
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2016.131
– volume: 6
  start-page: 369
  year: 2012
  ident: 2582_CR52
  publication-title: Patient Prefer Adherence
  doi: 10.2147/PPA.S29716
– volume: 11
  start-page: 709
  year: 2010
  ident: 2582_CR2
  publication-title: Expert Opin Pharmacother
  doi: 10.1517/14656561003614781
– volume: 1118
  start-page: 175
  year: 2019
  ident: 2582_CR3
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-030-05542-4_9
– volume: 17
  start-page: 359
  year: 2012
  ident: 2582_CR23
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2011.162
– volume: 240
  start-page: 146
  year: 2018
  ident: 2582_CR17
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2018.07.075
– volume: 19
  start-page: 477
  year: 2019
  ident: 2582_CR60
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0165-0
– volume: 9
  start-page: 1618
  year: 2020
  ident: 2582_CR76
  publication-title: Cells.
  doi: 10.3390/cells9071618
SSID ssj0000548171
Score 2.4020596
Snippet There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to...
Abstract There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 294
SubjectTerms 38/90
38/91
631/378/2584/2585
692/53/2423
692/699/476/1414
Behavioral Sciences
Biological Psychology
Electroconvulsive therapy
Medicine
Medicine & Public Health
Mental depression
MicroRNAs
Neurosciences
Pharmacotherapy
Psychiatry
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqDqiXqqWtmhaQK3FrI_ArcY4FgVAlekAgcbMcP9Stlixidw898N-Zsb0LQaJceos2jpJ4ZjLft_MiZA9QctAitLVTWJKjhK37zh_UOAsyAAIRKmA18tmv5vRS_rxSV49GfWFOWG4PnDdu30vhhO9lY20n4Ug3Wva27z33EeBIqiMHn_eITOWu3lKzlpUqmQOh9-fwtcZqMo5hSwWwUo48UWrYP0KZT3MknwRKk_85eUveFOBIf-QHfkdehWGLbJ6V0Ph7cndoU215oFPMA5rTWaTXk_MaHHMtbqjDKRxTAJYU_3mlAPtoTuUoXztcXkbiYCL6copp7TRXZ_2lk4GWBqzzfP21_TO7pes02uEDuTw5vjg6rctsBRAK04s6KhUZ514hAfIqAK7jwYaGsdY56SVzsY0dWDjQExc4i0xG3tgWtp7ZyIL4SDaG2RA-EWqd77noVK9lQO9meQskqpONRrLpdEXYap-NK43Hcf7F1KQAuNAmy8aAbEySjZEV-ba-5ia33fjn6kMU33oltsxOP4AimaJI5iVFqsj2Svim2PHccN0gAdVaVeTr-jRYIIZV7BBmy7wGaCgQz4rokdKMHmh8Zpj8Tr28gQ13LbDEinxf6dfD3Z9_48__442_kNc82UNXM7FNNha3y7ADEGvR7yZruge3FSPR
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9QwFA-6gngRP7G6SgRvWnbz1aQnccVlEdaDuDC3kCapjsy2s9OZgwf_d99LM1264N5Km9CmLy_5_fK-CHkHKDkaEXXpFYbkKOHKpg7HJdaCjIBAhIoYjXz-rTq7kF8XapEP3IbsVrlfE9NCHXqPZ-RH3FRIBYxRH9dXJVaNQutqLqFxl9zD1GXo0qUXejpjAThimGY5VuZYmKMB1myMKeNovFQALuVsP0pp-2dY86an5A1zadqFTh-Rhxk-0k-jvB-TO7F7Qu6fZwP5U_L3xKUI80hX6A000L6ll8vvJWzPpVhTj7U4VgAvKZ6_UgB_dHToyGseNs-FcdAdfbdC53Y6xmj9ocuO5jSsw9j_0v3uN3Rypu2ekYvTLz8-n5W5wgKIhplt2SrVMs6DQhoUVAR0x6OLFWPaexkk861ua9BzICk-ctYy2fLK6cY1zLUsiufkoOu7-IJQ50PDRa0aIyPucY5roFK1rAxSTm8Kwvb_2fqcfhyrYKxsMoMLY0fZWJCNTbKxsiDvpz7rMfnGra1PUHxTS0ycnW70m58266ENUngRGlk5V0u4MpWRMJom8NACutUFOdwL32ZtHuz13CvI2-kx6CEaV1wX-93YBsgo0M-CmNmkmX3Q_Em3_JUyegMnrjVwxYJ82M-v67f_f8Qvb__YV-QBTzO9Lpk4JAfbzS6-Bgi1bd4kPfkHKVYaMA
  priority: 102
  providerName: ProQuest
Title Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression
URI https://link.springer.com/article/10.1038/s41398-023-02582-4
https://www.proquest.com/docview/2864013885
https://www.proquest.com/docview/2864619716
https://pubmed.ncbi.nlm.nih.gov/PMC10497550
https://doaj.org/article/d43c3db46aa94c3d8684babbd2df0457
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEC72AeJFfGJ0HVrwpsHtV9I5zgy7LAO7yOrC3EIn6ejIbLLM4-DB_25VpxPJooKnGSbVTJKq7v6-rhfAO0TJzkiXxqWmlBwtbVxk1WlMvSAdIhCpHWUjX14lFzdqsdTLAxB9LowP2vclLf0y3UeHfdziYkvJYIK8jhpRoTqEYyrdTlY9T-bDuQpCEMNTHvJjTqX5w9DRHuRL9Y_w5f3oyHsuUr_znD-GRwEysml3k0_gwDVP4cFlcIo_g58z67PKHVtTBNCWtTW7XV3HuCXH8o6V1H9jjZCS0ZkrQ8DHuiCOsM6ReGiGQyHo-zUFtLMuL-sHWzUslF7dduNv7fd2w4YA2uY53JyffZlfxKGrAqqDm11ca11zISpN1KfSDhGdcNYlnKdlqSrFyzqtM5zbSExKJ3jNVS0Smxa24LbmTr6Ao6Zt3EtgtqwKITNdGOVoX7MiRfqUqcQQzSxNBLx_z3kZSo5T54t17l3f0uSdbnLUTe51k6sI3g9j7rqCG_-UnpH6Bkkqlu1_aDdf82A8eaVkKatCJdZmCr-ZxCh8mqISVY2INo3gpFd-HmbwNhcmIeppjI7g7XAZ5x45VGzj2n0ngwQUKWcEZmQ0oxsaX2lW33wVb-TBWYr8MIIPvX39_ve_P_Gr_xN_DQ-Ft_ws5vIEjnabvXuDMGpXTOAwXaYTOJ5OF58X-Dk7u_p0PfGzaeKPJn4BYsQc8g
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiKcaKGAkOEHU-pU4B4RYaLWl3RWqWqk34zgOLNomyz6EeuAv8RuZSZytthK99RYlTuJkxvb3eV6EvAaU7LXwaewUhuQoYeM8K3ZjrAXpAYEI5TEaeThKBqfyy5k62yB_u1gYdKvs5sRmoi5qh3vkO1wnSAW0Vh-mv2KsGoXW1a6ERqsWh_7iN1C2-fuDzyDfN5zv7518GsShqgB0h-lFXCpVMs4LhdC_UB4QDffWJ4ylzslCMlemZQa6DcDcec5KJkue2DS3ObMl8wKee4tsSgFUpkc2-3ujr8erXR0AQJqlLETn7Aq9M4dVAqPYOJpLFcBZubYCNoUC1tDtVd_MKwbaZt3bv0_uBcBKP7Ya9oBs-OohuT0MJvlH5E_fNjHtnk7Q_2hO65Kej49jAASxmFKH1T8mAGgp7vhSgJu0dSEJsyw2D6V40AF-OUF3etpGhV3QcUVD4td5e_-5_VnP6Mp9t3pMTm_k7z8hvaqu_Bah1hU5F5nKtfS4qlqeAnnLZKKR5DodEdb9Z-NCwnOsuzExjeFdaNPKxoBsTCMbIyPydnXPtE33cW3rPopv1RJTdTcn6tl3E0a-KaRwoshlYm0m4UgnWsLX5AUvSsDTaUS2O-GbMH_MzaW2R-TV6jKMfDTn2MrXy7YN0F8gvBHRa0qz1qH1K9X4R5NDHFh4lgI7jci7Tr8u3_7_L356fWdfkjuDk-GROToYHT4jd3mj9VnMxDbpLWZL_xwA3CJ_EUYNJd9ueqD-A9VMWHU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiKcIFDASnCDa-hU7B4QoZdVSWiFEpb0Zx3HKom2y7EOoB_4Yv46ZxNlqK9Fbb6uNs-tkxuPv87wIeQkoORgRdOoVpuQo4dIiL3dS7AUZAIEIFTAb-eg42z-Rn0ZqtEH-9rkwGFbZ28TWUJeNxzPyATcZUgFj1KCKYRFf9obvpr9S7CCFnta-nUanIofh_DfQt_nbgz2Q9SvOhx-_fdhPY4cBmBozi7RSqmKclwppQKkCoBseXMgY097LUjJf6SoHPQeQ7gNnFZMVz5wuXMFcxYKA371BbmqhGK4xPdKr8x2AQoZpFvN0doQZzGG_wHw2jo5TBcBWru2FbcuANZx7OUrzkqu23QGHd8jtCF3p-07X7pKNUN8jW0fROX-f_Nl1bXZ7oBOMRJrTpqJn468pQINUTKnHPiATgLYUz34pAE_aBZNEe4vDY1MeDIVfTjCwnnb5Yed0XNNYAnbe3X_mfjYzugrkrR-Qk2t59w_JZt3U4RGhzpcFF7kqjAy4vzqugcblMjNId71JCOvfs_Wx9Dl24JjY1gUvjO1kY0E2tpWNlQl5vbpn2hX-uHL0LopvNRKLdrdfNLNTG22ALaXwoixk5lwu4ZPJjISnKUpeVoCsdUK2e-HbaEnm9kLvE_JidRlsADp2XB2aZTcGiDBQ34SYNaVZm9D6lXr8o60mDnw818BTE_Km16-Lf___Ez--erLPyRYsT_v54PjwCbnFW6XPUya2yeZitgxPAcktimftkqHk-3Wv0X8BFVtF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Baseline+levels+of+miR-223-3p+correlate+with+the+effectiveness+of+electroconvulsive+therapy+in+patients+with+major+depression&rft.jtitle=Translational+psychiatry&rft.au=Kaurani%2C+Lalit&rft.au=Besse%2C+Matthias&rft.au=Methfessel%2C+Isabel&rft.au=Methi%2C+Aditi&rft.date=2023-09-13&rft.issn=2158-3188&rft.eissn=2158-3188&rft.volume=13&rft.issue=1&rft.spage=294&rft_id=info:doi/10.1038%2Fs41398-023-02582-4&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2158-3188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2158-3188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2158-3188&client=summon